COLL Price / Book | Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc. (COLL) Price / Book

2026-08-27: Price/Book Ratio 2.76.
2026-06-30: Price/Book Ratio 3.77.
2026-03-31: Price/Book Ratio 3.43.
2025-12-31: Price/Book Ratio 4.87.

Historical market capitalization divided by filed shareholder equity.

Available history: 2015-06-30 to 2026-08-27
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-08-27	2.76
2026-06-30	3.77
2026-03-31	3.43
2025-12-31	4.87
2025-09-30	4.02
2025-06-30	4.02
2025-03-31	4.09
2024-12-31	3.94
2024-09-30	5.32
2024-06-30	4.81
2024-03-31	5.71
2023-12-31	5.02
2023-09-30	4.13
2023-06-30	3.72
2023-03-31	4.62
2022-12-31	4.03
2022-09-30	2.74
2022-06-30	3.06
2022-03-31	3.52
2021-12-31	3.1
2021-09-30	2.74
2021-06-30	3.32
2021-03-31	4.91
2020-12-31	3.73
2020-09-30	4.17
2020-06-30	3.88
2020-03-31	3.97
2019-12-31	7.93
2019-09-30	4.57
2019-06-30	5.12
2019-03-31	5.85
2018-12-31	6.24
2018-09-30	6.92
2018-06-30	9.57
2018-03-31	9.29
2017-12-31	5.81
2017-09-30	3.35
2017-06-30	3.87
2017-03-31	2.59
2016-12-31	3.39
2016-09-30	6.11
2016-06-30	2.83
2016-03-31	3.51
2015-12-31	6.7
2015-09-30	4.89
2015-06-30	3.6

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Faeth Therapeutics, Inc. (FTH)	United States	$0.750B
Design Therapeutics, Inc. (DSGN)	United States	$0.766B	-12.78
Verastem, Inc. (VSTM)	United States	$0.706B	-1.71
Nuvectis Pharma, Inc. (NVCT)	United States	$0.705B	-17.53
IRONWOOD PHARMACEUTICALS INC (IRWD)	United States	$0.694B	5.37
Wave Life Sciences, Inc. (WVE)		$0.780B	-5.56
Olema Pharmaceuticals, Inc. (OLMA)	United States	$0.790B	-5.35
Climb Bio, Inc. (CLYM)	United States	$0.683B	-13.03
Aclaris Therapeutics, Inc. (ACRS)	United States	$0.792B	-9.78
GERON CORP (GERN)	United States	$0.803B	-12.14